:SWEDEHEART

Michael Dismorr1, Malin Granbom-Koski1, Emma Ellfors2

  • 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Cardiothoracic Surgery, Karolinska University Hospital, Stockholm, Sweden.

American heart journal
|August 11, 2024
PubMed
概括

雌性经历更好的生存率和更低的出血风险经过过导管大动脉置换 (TAVR). 这些发现强调了在TAVR患者管理中考虑性别特异性因素的重要性.